RIL
Rothschild Investment LLC Portfolio holdings
AUM
$1.6B
1-Year Return
17.99%
This Quarter Return
+9.71%
1 Year Return
+17.99%
3 Year Return
+73.94%
5 Year Return
+135.61%
10 Year Return
+254.21%
AUM
$1.6B
AUM Growth
+$101M
(+6.8%)
Cap. Flow
-$4.27M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
3,233
New
209
Increased
1,380
Reduced
863
Closed
217
Top Buys
Top Sells
| 1 |
Novo Nordisk
NVO
|
+$7.27M |
| 2 |
Kenvue
KVUE
|
+$4.89M |
| 3 |
FPF
First Trust Intermediate Duration Preferred & Income Fund
FPF
|
+$3.13M |
| 4 |
Nuveen Preferred & Income Opportunities Fund
JPC
|
+$2.87M |
| 5 |
Apple
AAPL
|
+$2.73M |
Sector Composition
| 1 | Technology | 18.15% |
| 2 | Financials | 13.7% |
| 3 | Industrials | 9.06% |
| 4 | Healthcare | 7.79% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Gannett
GCI
$620M
| $1.9K | ﹤0.01% |
530
+345
| +186% | +$1.24K |
|
2102
Middlesex Water
MSEX
$971M
| $1.9K | ﹤0.01% |
35
+25
| +250% | +$1.35K |
|
2103
Sealed Air
SEE
$4.99B
| $1.89K | ﹤0.01% |
61
+20
| +49% | +$621 |
|
2104
Skechers
SKX
$9.49B
| $1.89K | ﹤0.01% |
30
| – | – |
|
2105
Evercore
EVR
$13.2B
| $1.89K | ﹤0.01% |
7
+6
| +600% | +$1.62K |
|
2106
Cohen & Steers
CNS
$3.65B
| $1.88K | ﹤0.01% |
25
-35
| -58% | -$2.64K |
|
2107
EyePoint Pharmaceuticals
EYPT
$920M
| $1.88K | ﹤0.01% |
200
+80
| +67% | +$753 |
|
2108
Scansource
SCSC
$974M
| $1.88K | ﹤0.01% |
45
+30
| +200% | +$1.25K |
|
2109
GigaCloud Technology
GCT
$1.12B
| $1.88K | ﹤0.01% |
95
+20
| +27% | +$396 |
|
|
BBT
2110
Beacon Financial Corporation
BBT
$2.17B
| $1.88K | ﹤0.01% |
75
-20
| -21% | -$501 |
|
2111
Champion Homes, Inc.
SKY
$4.22B
| $1.88K | ﹤0.01% |
30
-45
| -60% | -$2.82K |
|
2112
Standex International
SXI
$2.47B
| $1.88K | ﹤0.01% |
12
-13
| -52% | -$2.04K |
|
2113
MidWestOne Financial Group
MOFG
$604M
| $1.87K | ﹤0.01% |
65
+15
| +30% | +$432 |
|
|
SAGE
2114
DELISTED
Sage Therapeutics
SAGE
| $1.87K | ﹤0.01% |
205
-225
| -52% | -$2.05K |
|
2115
Cantaloupe
CTLP
$792M
| $1.87K | ﹤0.01% |
170
+55
| +48% | +$604 |
|
2116
Manitowoc
MTW
$362M
| $1.86K | ﹤0.01% |
155
+65
| +72% | +$781 |
|
2117
DigitalOcean
DOCN
$3.25B
| $1.86K | ﹤0.01% |
65
-60
| -48% | -$1.71K |
|
2118
Maravai LifeSciences
MRVI
$386M
| $1.86K | ﹤0.01% |
770
+615
| +397% | +$1.48K |
|
2119
Match Group
MTCH
$9.08B
| $1.85K | ﹤0.01% |
60
+31
| +107% | +$957 |
|
2120
Relay Therapeutics
RLAY
$688M
| $1.85K | ﹤0.01% |
535
+325
| +155% | +$1.12K |
|
2121
CorVel
CRVL
$4.39B
| $1.85K | ﹤0.01% |
18
-21
| -54% | -$2.16K |
|
2122
Core Laboratories
CLB
$581M
| $1.84K | ﹤0.01% |
160
-85
| -35% | -$979 |
|
2123
World Kinect Corp
WKC
$1.41B
| $1.84K | ﹤0.01% |
65
-20
| -24% | -$567 |
|
|
KREF
2124
KKR Real Estate Finance Trust
KREF
$630M
| $1.84K | ﹤0.01% |
210
+55
| +35% | +$482 |
|
2125
AngioDynamics
ANGO
$433M
| $1.84K | ﹤0.01% |
185
+160
| +640% | +$1.59K |
|